FSCN1 and cancer: Moreover, FSCN1 overexpression was associated with advanced cancer stage, poorer histological differentiation, and survival rate of mucinous carcinoma, suggesting a potential role of FSCN1 as a candidate biomarker for aggressive serous and mucinous carcinomas [139].